Nhung Trinh

With Bessegen, my summer hiking season of 2024 comes to an end 🥳

Do you plan on publishing a #disproportionality_analysis? Here the first #guidelines_for_reporting it: #READUS_PV! Now available on Drug Safety thanks to a massive collaboration between pharmacovigilance experts. doi.org/10.1007/s40264…

👉 Just published The READUS-PV guidelines on the Reporting of a Disproportionality Analysis for Drug Safety Signal Detection link.springer.com/article/10.100… link.springer.com/article/10.100… #OpenAcess #Pharmacovigilance

We welcome contributions from Original Research to Review Articles, Clinical Trials, Study Protocols and Case Series related to safety aspects of medication use in the perinatal periods!

With Michael Ceulemans and @SarahObican, we recently launched a new Research Topic entitled "Drug Safety in the Perinatal Period" at Frontiers in Drug Safety and Regulation. Please consider this topic for your future submissions frontiersin.org/research-topic…

Vaccination reduced the risk of #LongCovid by ~40% in the entire population (5.4 million) of Norway thelancet.com/journals/lanre… and reduced cardiovascular and thrombotic events @NhungPharma @LancetRespirMed

This replication cannot be done without the OMOP Common Data Model and the OHDSI federated analytic pipeline! Many thanks to all the colleagues that were involved! And yes, let's do this more @prieto_alhambra

An unconventional way to celebrate Lunar New Year 🐲🐉

We have exciting projects on drug repurposing in the era of large-scale observational and genetic data for MSCA postdoc candidates within the DS Train program at University of Oslo! Take a look lnkd.in/dRHKDX6H and apply here lnkd.in/d2CZDv4T

@MarleenvGelder Yes, you did 😅 but I found a perfect location for the next Pharmasafe seminar and aurora 😍

@NhungPharma Did I leave one day too early?

Aurora is really a thing in Norway 😅

@MarleenvGelder 🥳

Honored to have received the Best PharmacoepiSLAM Award for my 3-minute presentation on NSAID exposure during pregnancy in relation to miscarriage risk during the #NorPEN conference. 🔥

@prieto_alhambra And thank you for accepting our invitation, we are all waiting for you Dani! See you tomorrow!

@MK_statistics Thank you @MK_statistics! It was a great pleasure to have you with us. We all enjoyed your lecture. Looking forward to your keynote talk today!

Amazing experience to run the 1-day NorPEN pre-conference course on Target Trial Emulation fhi.no/en/ab/conferen…  (140 participants; 85 in-person, 55 online)👏👏👏 I would like to thank @NhungPharma. A Desalegn and A Lupattelli for the invitation!

A bit of autumn in Northern Italy 🍁🍂